Search

Displaying results 221 - 230 of 441 in total
  1. Drug

    Tabirafusp alfa

    go.drugbank.com/drugs/DB21764
    Investigational

    Synonyms: Tabirafusp alfa
  2. Drug

    Betula pendula pollen

    go.drugbank.com/drugs/DB11004
    Approved

    Betula pendula pollen allergenic extract is used in allergenic testing.

    Synonyms: Betula alba var. pendula pollen
  3. Drug

    ALT-801

    go.drugbank.com/drugs/DB15386
    Investigational

    ALT-801 is under investigation in clinical trial NCT01478074 (ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia).

  4. Drug

    Ala-geninthiocin

    go.drugbank.com/drugs/DB15657
    Experimental

    Ala-geninthiocin is a novel thiopeptide antibacterial compound derived from marine _Streptomyces_ species.

    Synonyms: Ala-geninthiocin
  5. Drug

    Efprezimod alfa

    go.drugbank.com/drugs/DB16448
    Investigational

    CD24Fc is a biological immunomodulator originally developed to address graft-versus-host disease in stem cell transplantation in leukemia patients.

    Synonyms: Efprezimod alfa
  6. Drug

    Alidornase alfa

    go.drugbank.com/drugs/DB18144
    Experimental

    Synonyms: Alidornase alfa
  7. Drug

    Cinrebafusp alfa

    go.drugbank.com/drugs/DB18402
    Investigational

    Synonyms: Cinrebafusp alfa
  8. Drug

    Interferon alfa-2c

    go.drugbank.com/drugs/DB15131
    Investigational

    Interferon alfa-2c is under investigation in clinical trial NCT00485563 (A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma).

    Synonyms: Interferon alfa-2c
  9. Drug

    Marzeptacog alfa (activated)

    go.drugbank.com/drugs/DB15278
    Investigational

    Marzeptacog alfa (activated) is under investigation in clinical trial NCT01439971 (Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects

    Synonyms: Marzeptacog alfa (activated)
  10. Drug

    ALT-P1

    go.drugbank.com/drugs/DB18485
    Investigational

    ALT-P1 is a long-acting recombinant human growth hormone fused to an alpha1-antitrypsin variant. It is under investigation for the treatment of growth hormone deficiency.